Advice alone versus structured detoxification programmes for complicated medication overuse headache (MOH): a prospective, randomized, open-label trial

Paolo Rossi, Jessica Veronica Faroni, Cristina Tassorelli, Giuseppe Nappi, Paolo Rossi, Jessica Veronica Faroni, Cristina Tassorelli, Giuseppe Nappi

Abstract

Background: The aim of this study was to compare the effectiveness of an educational strategy (advice to withdraw the overused medication/s) with that of two structured pharmacological detoxification programmes in patients with complicated medication overuse headache (MOH) plus migraine.

Methods: One hundred and thirty-seven complicated MOH patients participated in the study. MOH was defined as complicated in patients presenting at least one of the following: a) a diagnosis of co-existent and complicating medical illnesses; b) a current diagnosis of mood disorder, anxiety disorder, eating disorder, or substance addiction disorder; c) relapse after previous detoxification treatment; d) social and environmental problems; e) daily use of multiple doses of symptomatic medications. Group A (46 patients) received only intensive advice to withdraw the overused medication/s. Group B (46 patients) underwent a standard detoxification programme as outpatients (advice+steroids+preventive treatment). Group C (45 patients) underwent a standard inpatient withdrawal programme (advice+steroids+fluid replacement and antiemetics preventive treatment). Withdrawal therapy was considered successful if, after two months, the patient had reverted to an intake of NSAIDs lower than 15 days/month or to an intake of other symptomatic medication/s lower than 10 days/month.

Results: Twenty-two patients failed to attend follow-up visits (11 in Group A, 9 in Group B, 2 in Group C, p<0.03). Overall, we detoxified 70% of the whole cohort, 60.1% of the patients in Group A and in Group B, and 88.8% of those in Group C (p<0.01).

Conclusions: Inpatient withdrawal is significantly more effective than advice alone or an outpatient strategy in complicated MOH patients.

Figures

Figure 1
Figure 1
Outline of the trial.

References

    1. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010;14:391–401. doi: 10.1016/S1474-4422(10)70008-9.
    1. Dodick DW, Silberstein SD. How clinicians can detect, prevent and treat medication overuse headache. Cephalalgia. 2008;14:1209–1217.
    1. Aaseth K, Grande RB, Kvaerner KJ, Gulbrandsen P, Lundqvist C, Russell MB. Prevalence of secondary chronic headaches in a population-based sample of 30–44-year-old persons. The Akershus study of chronic headache. Cephalalgia. 2008;14:705–713. doi: 10.1111/j.1468-2982.2008.01577.x.
    1. Colas R, Munoz P, Temprano R, Gomez C, Pascual J. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004;14:1338–1342. doi: 10.1212/01.WNL.0000120545.45443.93.
    1. Katsarava Z, Dzagnidze A, Kukava M. et al.Primary headache disorders in the Republic of Georgia: prevalence and risk factors. Neurology. 2009;14:1796–1803. doi: 10.1212/WNL.0b013e3181c34abb.
    1. Straube A, Pfaffenrath V, Ladwig KH, Meisinger C, Hoffmann W, Fendrich K, Vennemann M, Berger K. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2009;14:207–213.
    1. Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011;14:1015–1022. doi: 10.1177/0333102411410082.
    1. Linde M, Gustavsson A, Stovner LJ, Steiner TJ, Barré J, Katsarava Z, Lainez JM, Lampl C, Lantéri-Minet M, Rastenyte D, Ruiz de la Torre E, Tassorelli C, Andrée C. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012;14:703–711. doi: 10.1111/j.1468-1331.2011.03612.x.
    1. Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD, Steiner TJ. Headache Classification Committee. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006;14:742–746.
    1. Negro A, Martelletti P. Chronic migraine plus medication overuse headache: two entities or not. J Headache Pain. 2011;14:593–601. doi: 10.1007/s10194-011-0388-3.
    1. Farinelli I, Dionisi I, Martelletti P. Rehabilitating chronic migraine complicated by medication overuse headache: how we can prevent migraine relapse? Intern Emerg Med. 2011;14:23–28. doi: 10.1007/s11739-010-0410-9.
    1. Katsarava Z, Jensen R. Medication overuse headache: where are we now? Curr Opin Neurol. 2007;14:326–330. doi: 10.1097/WCO.0b013e328136c21c.
    1. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006;14:1894–1898. doi: 10.1212/.
    1. Rossi P, Jensen R, Nappi G, Allena M. COMOESTAS Consortium. A narrative review on the management of medication overuse headache: the steep road from experience to evidence. J Headache Pain. 2009;14:407–417. doi: 10.1007/s10194-009-0159-6.
    1. Olesen J. Detoxification for medication overuse headache is the primary task. Cephalalgia. 2012;14:420–422. doi: 10.1177/0333102411431309.
    1. Diener HC. Detoxification for medication overuse headache is not necessary. Cephalalgia. 2012;14:423–427. doi: 10.1177/0333102411425867.
    1. Pamelaire K, Crevits L, Goadsby PJ, Kaube H. Practical management of medication overuse headache. Acta Neurol Belg. 2006;14:43–51.
    1. Obermann M, Katsarava Z. Management of medication overuse headache. Expert Rev Neurother. 2007;14:1145–1155. doi: 10.1586/14737175.7.9.1145.
    1. Diener HC, Limmroth V. Medication-overuse headache: a worldwide problem. Lancet Neurol. 2004;14:475–483. doi: 10.1016/S1474-4422(04)00824-5.
    1. Evers S, Jensen R. European Federation of Neurological Societies. Treatment of medication overuse headache – guideline of the EFNS headache panel. Eur J Neurol. 2011;14:1115–1121. doi: 10.1111/j.1468-1331.2011.03497.x.
    1. Radat F, Lanteri-Minet M. What is the role of dependence-related behavior in medication overuse headache? Headache. 2010;14:1587–1611. doi: 10.1111/j.1526-4610.2010.01757.x.
    1. Saper JR, Hamel RL, Lake AE III. Medication overuse headache (MOH) is a biobehavioural disorder. Cephalalgia. 2005;14:545–546. doi: 10.1111/j.1468-2982.2005.00879.x.
    1. Lake AE III. Medication overuse headache: biobehavioural issues and solutions. Headache. 2006;14(Suppl 3):S88–S97.
    1. Rossi P, Di Lorenzo C, Faroni J, Cesarino F, Nappi G. Advice alone vs structured detoxification programmes for medication overuse headache: a prospective, randomized, open-label trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;14:1097–1105. doi: 10.1111/j.1468-2982.2006.01175.x.
    1. Hagen K, Albretsen C, Vilming ST, Salvesen R, Grønning M, Helde G, Gravdahl G, Zwart JA, Stovner LJ. Management of medication overuse headache: 1 year randomized multicentre open-label trial. Cephalalgia. 2009;14:221–232. doi: 10.1111/j.1468-2982.2008.01711.x.
    1. Grande RB, Aaseth K, Benth JS, Lundqvist C, Russell MB. Reduction in medication overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011;14:129–137. doi: 10.1111/j.1468-1331.2010.03094.x.
    1. Creac’h C, Frappe P, Cancade M, Laurent B, Peyron R, Demarquay G, Navez M. In-patient versus out-patient withdrawal programmes for medication overuse headache. A 2-year randomized trial. Cephalalgia. 2011;14:1189–1198. doi: 10.1177/0333102411412088.
    1. Munsksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: a comparison of two consecutive treatment methods in open-label design. Cephalalgia. 2012;14:834–844. doi: 10.1177/0333102412451363.
    1. Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2011;14:396–401. doi: 10.1111/j.1468-1331.2010.03157.x.
    1. Mazza F, Morosini P, De Girolamo G, Lussettie G, Guaraldi GP. SCID-I CV: Edizione italiana. O.S. Organizzazioni Speciali, Florence; 2000.
    1. Munksgaard SB, Allena M, Tassorelli C, Rossi P, Katsarava Z, Bendtsen L, Nappi G, Jensen R. Comoestas Consortium. What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information? J Headache Pain. 2011;14:91–96. doi: 10.1007/s10194-011-0298-4.
    1. Lundqvist C, Grande RB, Aaseth K, Russell MB. Dependence scores predict prognosis of medication overuse headache: a prospective cohort from the Akershus study of chronic headache. Pain. 2012;14:682–686. doi: 10.1016/j.pain.2011.12.008.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa